Last reviewed · How we verify
CG2001
At a glance
| Generic name | CG2001 |
|---|---|
| Sponsor | Beijing Dayspring Pharmaceutical Technology Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia (PHASE2)
- Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CG2001 CI brief — competitive landscape report
- CG2001 updates RSS · CI watch RSS
- Beijing Dayspring Pharmaceutical Technology Co., Ltd portfolio CI